Results 81 to 90 of about 16,632 (223)

Cardiac autonomic control in Brugada syndrome patients during sleep : the effects of sleep disordered breathing [PDF]

open access: yes, 2013
Aims Brugada syndrome is characterized by typical ECG features, ventricular arrhythmias and sudden cardiac death (SCD), more frequent during nighttime. Autonomic cardiovascular control has been implicated in triggering the ventricular arrhythmias.
J. Brugada   +10 more
core   +1 more source

R1 Prognostic Significance of T‐Wave Amplitude Variability for Adverse Cardiovascular Outcomes: A Systematic Review and Meta‐Analysis

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
In this systematic review and meta‐analysis of seven studies involving 1366 patients, elevated T‐wave amplitude variability (TAV) was associated with a 2.5‐fold higher risk of adverse cardiovascular outcomes. These findings support TAV as a marker of ventricular repolarization instability for long‐term risk stratification.
Yoshihiro Sobue   +5 more
wiley   +1 more source

Brugada Syndrome and PKP2: Evidences and uncertainties [PDF]

open access: yes, 2016
Common electrocardiographic patterns in Brugada Syndrome and Arrhythmogenic Cardiomyopathy have been reported despite phenotypic alterations during its clinical course.
Fernández-Falgueras, Anna   +3 more
core   +1 more source

Sudden cardiac death due to adrenal insufficiency masquerading as Brugada syndrome. Case report

open access: yesЕвразийский Кардиологический Журнал
Sudden cardiac death in young people in 20% of cases is caused by cardiomyopathies and channelopathies. One of the forms of channelopathies is Brugada syndrome, a hereditary disease characterized by ST segment elevation in the right precordial leads (V1 ...
N. V. Kijvatova   +4 more
doaj   +1 more source

Midterm Efficacy of SubcutAneous Implantable CardioVErter‐Defibrillator in ≤ 18 Year‐Old CHILDREN (SAVE CHILDREN‐II Registry)

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
S‐ICD therapy demonstrated favorable mid‐term safety and efficacy in pediatric patients, with durable sensing performance and a low incidence of device‐related infection. ABSTRACT Background The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) avoids transvenous leads and is a promising option for sudden cardiac death (SCD) prevention in ...
Hitoshi Mori   +76 more
wiley   +1 more source

Brugada phenocopies are the leading differential diagnosis of Brugada syndrome [PDF]

open access: yesClinical Medicine, 2015
OVERVIEW Please submit letters for the editor9s consideration within three weeks of receipt of Clinical Medicine.
Byron H, Gottschalk   +2 more
openaire   +2 more sources

Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients. [PDF]

open access: yes, 2017
BACKGROUND: Data on the age at first arrhythmic event (AE) in Brugada syndrome are from limited patient cohorts. The aim of this study is 2-fold: (1) to define the age at first AE in a large cohort of patients with Brugada syndrome, and (2) to assess the
Casado-Arroyo, R   +201 more
core   +1 more source

Simultaneous Transvenous Lead Extraction and Intra‐Operative Epicardial Extravascular Defibrillator (EV‐ICD) Implantation During Tricuspid Valve Replacement

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Transvalvular device leads are undesirable following tricuspid valve replacement. Simultaneous lead extraction and intra‐operative EV‐ICD implantation can provide ongoing defibrillator therapy without crossing the prosthetic valve and may avoid the need for additional pacing hardware when atrioventricular conduction is preserved.
Joseph Canavan   +3 more
wiley   +1 more source

Persistent Ischemia‐Like Electrocardiographic Changes in a Young Breast Cancer Patient on Trastuzumab: A Case Report

open access: yesCancer Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background Trastuzumab has changed the landscape of treatment for HER2‐positive breast cancer, offering a meaningful survival benefit. However, alongside its effectiveness, concerns remain about its potential impact on the heart, particularly when patients develop unexpected ECG changes during therapy without any obvious cardiac symptoms. Case
Azin Alizadehasl   +5 more
wiley   +1 more source

Brugada Syndrome or Brugada Electrocardiogram?

open access: yesJournal of the American College of Cardiology, 2009
We read with great interest the paper by Benito et al. ([1][1]) from the Brugada group. The authors confirm that important differences exist between men and women regarding the clinical picture and outcome in patients with Brugada syndrome.
van den Berg, Maarten P.   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy